| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.90M | 17.95M | 22.22M | 11.67M | 6.87M |
| Gross Profit | 6.98M | 8.82M | 11.78M | 5.57M | 2.52M |
| EBITDA | 800.05K | 2.09M | 5.68M | 1.57M | -1.81M |
| Net Income | -835.20K | 600.28K | 4.44M | 608.33K | -2.68M |
Balance Sheet | |||||
| Total Assets | 24.54M | 24.55M | 22.96M | 15.48M | 13.28M |
| Cash, Cash Equivalents and Short-Term Investments | 831.06K | 1.68M | 3.23M | 144.88K | 849.50K |
| Total Debt | 7.75M | 6.44M | 7.31M | 7.82M | 8.44M |
| Total Liabilities | 17.83M | 16.45M | 15.62M | 12.84M | 11.46M |
| Stockholders Equity | 6.62M | 8.00M | 7.25M | 2.54M | 1.73M |
Cash Flow | |||||
| Free Cash Flow | -3.37M | -594.48K | 4.57M | -292.54K | -1.96M |
| Operating Cash Flow | -3.20M | -256.31K | 5.55M | -82.77K | -1.81M |
| Investing Cash Flow | -169.65K | -328.33K | -965.82K | -209.77K | 122.77K |
| Financing Cash Flow | 2.52M | -962.02K | -1.50M | -412.09K | 2.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
45 Neutral | $7.56M | -1.83 | -93.87% | ― | -0.74% | 81.49% | |
44 Neutral | C$15.39M | -2.79 | ― | ― | 15.64% | 58.47% | |
41 Neutral | C$3.46M | -2.69 | -11.42% | ― | -5.87% | -239.53% | |
38 Underperform | C$3.84M | -1.33 | ― | ― | 1.60% | -213.10% |
CanadaBis Capital reported fiscal Q1 2026 results showing gross revenue of $5.7 million and net revenue of $3.3 million, with gross margin improving to 27.0% and positive operating cash flow of $0.4 million, despite a net loss and lower sales versus the prior year. Performance was weighed down by temporary labor disruptions at the British Columbia Liquor Distribution Branch, which the company estimates cost about $0.5 million in lost cannabis sales, but management highlighted benefits from recent cost and labour efficiency measures and a shift to higher-margin products, and underscored continued focus on liquidity by opting to pay upcoming convertible debenture interest in shares rather than cash, a move that preserves cash but dilutes equity holders while supporting balance sheet flexibility.
The most recent analyst rating on (TSE:CANB) stock is a Hold with a C$0.02 price target. To see the full list of analyst forecasts on CanadaBis Capital stock, see the TSE:CANB Stock Forecast page.
CanadaBis Capital Inc. has announced its proposal to reduce the conversion price of its outstanding Convertible Debentures from $0.10 to $0.075 per Common Share, subject to approval by the TSX Venture Exchange. Additionally, the company plans to pay the upcoming interest on these debentures through the issuance of common shares, rather than cash, to strengthen liquidity and align shareholder interests. These strategic moves are aimed at enhancing the company’s financial foundation and supporting its growth initiatives in the cannabis industry.
CanadaBis Capital Inc. announced its financial results for the fiscal year ending July 31, 2025, reporting gross revenue of $30.53 million and a gross profit of $7.38 million. Despite challenges in fiscal 2025, the company is focused on strategic initiatives to enhance sales growth and product margins, including securing favorable feedstock pricing agreements and expanding its national presence.